Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Betamethasone dipropionate
Drug ID BADD_D00261
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D01637
MeSH ID C011175
PubChem ID 21800
TTD Drug ID Not Available
NDC Product Code 22552-0028; 49452-1075; 65089-0009; 16714-996; 45802-376; 50090-5232; 0472-0381; 45802-505; 66993-897; 68788-9219; 71205-275; 72578-093; 0713-0659; 0168-0057; 0168-0265; 50090-4679; 63629-8613; 63629-9323; 63629-9324; 70518-3562; 68788-7241; 0472-0380; 70518-3701; 0713-0807; 38779-0017; 0168-0268; 45802-021; 51407-273; 70771-1380; 78206-124; 51927-0171; 50090-2182; 53002-8280; 63187-286; 68788-7670; 50090-0235; 51672-1309; 51672-1390; 63629-8614; 68462-290; 70710-1233; 70771-1550; 50090-4680; 51672-1340; 68071-2850; 68788-9804; 0472-0382; 51672-1274; 51672-1310; 51552-0022; 52128-160; 0168-0055; 0168-0056; 50090-1839; 51672-1317; 68040-714; 68180-947; 68788-0382; 46439-8710; 0168-0267; 50090-0236
UNII 826Y60901U
Synonyms betamethasone-17,21-dipropionate | betamethasone dipropionate | Diprosone | Diprolene | Beloderm | betamethasone propionate | Maxivate | augmented betamethasone dipropionate
Chemical Information
Molecular Formula C28H37FO7
CAS Registry Number 5593-20-4
SMILES CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Atrophy08.03.04.001--Not Available
Blister23.03.01.001; 12.01.06.002--Not Available
Burning sensation17.02.06.001; 08.01.09.029--Not Available
Cushing's syndrome24.08.04.001; 19.07.03.002; 14.11.01.007; 05.01.01.001--Not Available
Dermatitis23.03.04.002--Not Available
Dermatitis acneiform23.02.01.004--
Dermatitis contact12.03.01.040; 10.01.01.003; 23.03.04.004--Not Available
Dry skin23.03.03.001--
Erythema23.03.06.001--Not Available
Folliculitis23.11.04.003; 11.02.01.053--
Glycosuria20.02.01.005--
Hyperaesthesia23.03.03.080; 17.02.06.004--Not Available
Hyperglycaemia14.06.02.002; 05.06.02.002--
Hypertension24.08.02.001--
Hypertrichosis23.02.04.002--
Infection11.01.08.002--Not Available
Leukoderma23.05.02.001--Not Available
Miliaria23.02.03.014--Not Available
Pain08.01.08.004--
Papule23.03.03.038--Not Available
Paraesthesia23.03.03.094; 17.02.06.005--
Pruritus23.03.12.001--
Rash erythematous23.03.13.029--Not Available
Rash follicular23.03.10.001--Not Available
Skin atrophy23.01.05.001--
Skin depigmentation23.05.02.002--Not Available
Skin disorder23.03.03.007--Not Available
Skin hypopigmentation23.05.02.003--
Skin irritation23.03.04.009--Not Available
Skin striae23.01.05.002--Not Available
The 1th Page    1 2    Next   Last    Total 2 Pages